Page 79 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 79
General Session 2 & Award Ceremony 1 (Cont.) Hall D
ABSTRACT THE PHASE 3 C-EDGE TREATMENT-NAÏVE (TN) STUDY
OF A 12-WEEK ORAL REGIMEN OF GRAZOPREVIR (GZR,
G07 MK-5172)/ELBASVIR (EBR, MK-8742) IN PATIENTS WITH
08:30 - 08:45 CHRONIC HCV GENOTYPE (GT) 1, 4, OR 6 INFECTION
Stefan Zeuzem, Germany
SCIENTIFIC PROGRAMME
ABSTRACT MICROBIAL TRANSLOCATION IN LIVER FIBROSIS
INDUCES CHRONIC IFNAR SIGNALING THAT IMPAIRS
G11 INNATE IMMUNITY AGAINST BACTERIAL INFECTION
08:45 - 09:00 Zeinab Abdullah, Germany
ABSTRACT TARGETING A HOST-CELL ENTRY FACTOR BARRICADES
ANTIVIRAL RESISTANT HCV VARIANTS FROM ON-
G09 THERAPY BREAKTHROUGH IN HUMAN-LIVER MICE
09:00 - 09:15 Philip Meuleman, Belgium
09:15 - 09:45 Award Ceremony I
ABSTRACT MITOCHONDRIAL-TARGETED ANTIOXIDANT
MITOQUINONE REDUCES PORTAL HYPERTENSION
G10 IN CCL4-CIRRHOTIC RATS BY DECREASING
09:45 - 10:30 INTRAHEPATIC RESISTANCE
Marina Vilaseca Barceló, Spain
ABSTRACT INCIDENCE OF HEPATOCELLULAR CARCINOMA
(HCC) AND COMPLICATIONS IN ALCOHOLIC
G08 COMPENSATED CIRRHOSIS. PRELIMINARY RESULTS OF
10:00 - 10:15 A MULTICENTER PROSPECTIVE FRENCH AND BELGE
COHORT (INCA CIRRAL)
Nathalie Ganne, France
ABSTRACT THE BURDEN OF CARDIOVASCULAR DISEASE
AND MORTALITY ACROSS A SPECTRUM OF NON-
G12 ALCOHOLIC FATTY LIVER DISEASE: A 14-YEAR
10:15 - 10:30 FOLLOW-UP POPULATION STUDY OF 929,465
INDIVIDUALS
Jake P. Mann, The United Kingdom
Vienna, Austria • April 22–26, 2015 79
ABSTRACT THE PHASE 3 C-EDGE TREATMENT-NAÏVE (TN) STUDY
OF A 12-WEEK ORAL REGIMEN OF GRAZOPREVIR (GZR,
G07 MK-5172)/ELBASVIR (EBR, MK-8742) IN PATIENTS WITH
08:30 - 08:45 CHRONIC HCV GENOTYPE (GT) 1, 4, OR 6 INFECTION
Stefan Zeuzem, Germany
SCIENTIFIC PROGRAMME
ABSTRACT MICROBIAL TRANSLOCATION IN LIVER FIBROSIS
INDUCES CHRONIC IFNAR SIGNALING THAT IMPAIRS
G11 INNATE IMMUNITY AGAINST BACTERIAL INFECTION
08:45 - 09:00 Zeinab Abdullah, Germany
ABSTRACT TARGETING A HOST-CELL ENTRY FACTOR BARRICADES
ANTIVIRAL RESISTANT HCV VARIANTS FROM ON-
G09 THERAPY BREAKTHROUGH IN HUMAN-LIVER MICE
09:00 - 09:15 Philip Meuleman, Belgium
09:15 - 09:45 Award Ceremony I
ABSTRACT MITOCHONDRIAL-TARGETED ANTIOXIDANT
MITOQUINONE REDUCES PORTAL HYPERTENSION
G10 IN CCL4-CIRRHOTIC RATS BY DECREASING
09:45 - 10:30 INTRAHEPATIC RESISTANCE
Marina Vilaseca Barceló, Spain
ABSTRACT INCIDENCE OF HEPATOCELLULAR CARCINOMA
(HCC) AND COMPLICATIONS IN ALCOHOLIC
G08 COMPENSATED CIRRHOSIS. PRELIMINARY RESULTS OF
10:00 - 10:15 A MULTICENTER PROSPECTIVE FRENCH AND BELGE
COHORT (INCA CIRRAL)
Nathalie Ganne, France
ABSTRACT THE BURDEN OF CARDIOVASCULAR DISEASE
AND MORTALITY ACROSS A SPECTRUM OF NON-
G12 ALCOHOLIC FATTY LIVER DISEASE: A 14-YEAR
10:15 - 10:30 FOLLOW-UP POPULATION STUDY OF 929,465
INDIVIDUALS
Jake P. Mann, The United Kingdom
Vienna, Austria • April 22–26, 2015 79
